Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Journal of Hematopathology
Literature
1.
Colella R, Hollensead SC (2012) Understanding and recognizing the Pelger-Huet anomaly. Am J Clin Pathol 137(3):358–366CrossRef
2.
Teshima T, Shibuya T, Harada M, Taniguchi S, Nozaki M, Mori T, Mori Y, Tamai H, Niho Y (1991) Effects of G-CSF, GM-CSF, and IL-5 on nuclear segmentation of neutrophils and eosinophils in congenital or acquired Pelger-Huet anomaly. Exp Hematol 19(5):322–325PubMed
3.
Duployez N, Bories C (2020) Mature neutrophils with Auer rod bundles in CBFB-MYH11-positive acute myeloid leukemia. Int J Hematol 111(1):3–4CrossRef
4.
Feng Y (2019) Unusual sites of Auer rod in AML with t(8;21). Indian J Hematol Blood Transfus 35(3):601–602CrossRef
Metadata
Title
Coexistence of pseudo-Pelger-Hüet anomaly and faggot cells in acute promyelocytic leukemia during chemotherapy
Authors
Ting Li
Dongyan Li
Xueyan Chen
Publication date
01-09-2021
Publisher
Springer Berlin Heidelberg
Published in
Journal of Hematopathology / Issue 3/2021
Print ISSN: 1868-9256
Electronic ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-021-00461-9

Other articles of this Issue 3/2021

Journal of Hematopathology 3/2021 Go to the issue

Case Report

Hemophagocytic lymphohistiocytosis, a new cause of death during ‘post-acute COVID-19 syndrome?’ A case report

Case Report

Primary thyroid T cell lymphoproliferative disorder with a 10-year history of neck mass: a case report and literature review

Editorial

What, how, and when for the WHO: will the clock be turned back for the next hematolymphoid tumor classification?

Original Article

Multiple myeloma and frequency of synchronous and second primary malignancies

Original Article

The impact of CD33/CD34 ratio in the prognosis of myelodysplastic syndrome treated with azacitidine for first-line therapy

Original Article

CD37 and CD44 evaluation by flow cytometry: can these markers improve B cell lymphoma characterization?